Infection Control in the ICU Environment: Perspectives on Critical Care Infectious Diseases, cartea 5
Editat de Robert A. Weinstein, Marc Bontenen Limba Engleză Hardback – 31 dec 2001
Acinetobacter, methicillin resistant staphylococcus aureus and vancomycin resistant enterococci are examined in detail. This volume also includes cutting edge information regarding the potential for prophylactic and pre-emptive therapy of fungal infections in intensive care units.
Innovations in vascular catheter care and prevention of bloodstream infections are discussed in this volume as well as the newest information in mathematical modeling to understand the epidemiology and control of infections in intensive care units.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1071.91 lei 6-8 săpt. | |
Springer Us – 23 oct 2012 | 1071.91 lei 6-8 săpt. | |
Hardback (1) | 1079.98 lei 6-8 săpt. | |
Springer Us – 31 dec 2001 | 1079.98 lei 6-8 săpt. |
Preț: 1079.98 lei
Preț vechi: 1136.81 lei
-5% Nou
Puncte Express: 1620
Preț estimativ în valută:
206.72€ • 216.76$ • 170.80£
206.72€ • 216.76$ • 170.80£
Carte tipărită la comandă
Livrare economică 29 ianuarie-12 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792374152
ISBN-10: 0792374150
Pagini: 276
Ilustrații: XI, 276 p.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.62 kg
Ediția:2002
Editura: Springer Us
Colecția Springer
Seria Perspectives on Critical Care Infectious Diseases
Locul publicării:New York, NY, United States
ISBN-10: 0792374150
Pagini: 276
Ilustrații: XI, 276 p.
Dimensiuni: 155 x 235 x 22 mm
Greutate: 0.62 kg
Ediția:2002
Editura: Springer Us
Colecția Springer
Seria Perspectives on Critical Care Infectious Diseases
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. Scope and Magnitude of Nosocomial ICU Infections U.S. Perspective:.- 2. Scope xand Magnitude of Nosocomial ICU Infections European Perspective:.- 3. Vancomycin-Resistant Enterococci: A Threat for the ICU? U.S. Perspective:.- 4. Vancomycin-Resisitant Enterococci in Europe: A Changing Epidemiology? European Perspective:.- 5. Methicillin-Resistant Staphylococcus Aureus: Is Control Necessary? U.S. Perspective:.- 6. Acinetobacter: Epidemiology and Control U.S. Perspective:.- 7. Acinetobacter: Epidemiology and Control European Perspective:.- 8. Fungal Infections: The Role of Prophylactic and Empiric Antifungal Therapy in ICU Patients U.S. Perspective:.- 9. Fungal Infections: The Role of Prophylaxis and Empiric Therapy in ICU Patients European Perspective:.- 10. Newer Approaches to Preventing Vascular Catheter-Related Sepsis U.S. Perspective:.- 11. Newer Approaches to Preventing Intravascular Device-Related Bloodstream Infections European Perspective:.- 12. Is Prevention of Ventilator-Associated Pneumonia Cost Effective? North American Perspective:.- 13. Ventilator-Associated Pneumonia: Is Prevention Cost Effective? European Perspective:.- 14. Cross-Colonization in Intensive Care Units: Fact or Fiction? U.S. Perspective:.- 15. Cross-Colonization: Fact or Fiction? European Perspective:.- 16. Conventional Infection Control Measures: Value or Ritual? U.S. Perspective:.- 17. Conventional Infection Control Measures: Value or Ritual? European Perspective:.- 18. Modeling of Antibiotic Resistance in the ICU U.S. Perspective:.- 19. Mathematical Models in the ICU: Dynamics, Infection Control and Antibiotic Resistance European Perspective:.